PATK Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Execution CTS Q1 2026 Earnings Strong EPS Beat of 18 Drives Positive Stock Reaction Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD MGRD Q1 2026 Earnings EPS Beat Surprises Revenue Data Absent TSBK Q1 2026 Earnings Solid EPS Performance in Stable Quarter PGNY Q1 2026 Earnings EPS Falls Short of Estimates Despite Modest Stock Gain